62284-79-1,
L-p-BROMOTETRAMISOLE OXALATE,
(-)-p-Bromotetramisole oxalate,
(-)-4-Bromotetramisole oxalate,
S(-)-p-Bromotetramisole oxalate,
L-(-)-p-Bromotetramisole oxalate,
(-)-p-Bromotetramisole (oxalate),
6-Bromolevamisole oxalate salt,
(-)-p-Bromolevamisole oxalate,
(-)-4-Bromotetramisole oxalate salt,
(S)-(-)-4-Bromotetramisole oxalate,
(S)-6-(4-bromophenyl)-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole oxalate,
(S)-(-)-6-(4-Bromophenyl)-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole oxalate salt,
(S)-(-)-4-Bromotetramisole Oxalate;(-)-4-bromotetramisole oxalate salt;()-p-Bromolevamisole oxalate,
6-Bromolevamisole oxalate,
L(-)-p-bromotetramisole oxalate,
C11H11BrN2S.C2H2O4,
PubChem6166,
R 30402 oxalate,
EU-0100021,
AC1MC43I,
()-p-Bromolevamisole oxalate,
BMK1-H3,
MLS000860040,
CHEMBL1256792,
CTK8G0647,
(-)-p-Bromotetramisole(oxalate),
HMS2231M14,
HMS3260E03,
BCP16717,
KS-00001DG1,
Tox21_500021,
(-)-p-Bromolevamisole oxalate 99%,
(-)-p-Bromotetramisole oxalate salt,
2125AH,
s7383,
(-)-p-Bromolevamisole oxalate, 99%,
AKOS030526170,
CCG-221325,
CS-5385,
LP00021,
NCGC00093544-01,
NCGC00260706-01,
BC003102,
HY-19695,
SMR000326898,
MLS-0317970.P017,
FT-0640818,
ST50308584,
SW220284-1,
A14271,
SR-01000075599,
SR-01000075599-1,
S(-)-6-(4-Bromophenyl)-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole oxalate,
(6S)-6-(4-bromophenyl)-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole; oxalic acid,
(6S)-6-(4-bromophenyl)-2H,3H-2-imidazolino[2,1-b]1,3-thiazolidine, ethanedioic acid,
-4-BROMOTETRAMISOLEOXALATE,
EINECS 263-487-0,
CB10430,
CID2724023,
C11-H11-Br-N2-S.C2-H2-O4,
(S)-6-(p-Bromophenyl)-2,3,5,6-tetrahydroimidazo(2,1-b)thiazole oxalate,
(S)-6-(p-bromophenyl)-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole oxalate,